Literature DB >> 3789624

Skeletal effects of carcinoma of the breast and prostate.

R C Percival.   

Abstract

Recent research has led to improved understanding of the pathology of skeletal metastases in carcinoma of the breast and prostate. Several humoral mechanisms have been identified which have both primary and secondary consequences on skeletal metabolism and probably depend on the complex interplay of a number of factors derived from tumour tissues. An improved understanding of these interactions may lead to new approaches in the management of these common disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789624      PMCID: PMC2498336     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  20 in total

1.  Skeletal metastases and mammary cancer.

Authors:  C S Galasko
Journal:  Ann R Coll Surg Engl       Date:  1972-01       Impact factor: 1.891

Review 2.  Spread of prostatic cancer to bone.

Authors:  S C Jacobs
Journal:  Urology       Date:  1983-04       Impact factor: 2.649

3.  Generalised increase in bone resorption in carcinoma of the prostate.

Authors:  G H Urwin; R C Percival; S Harris; M N Beneton; J L Williams; J A Kanis
Journal:  Br J Urol       Date:  1985-12

4.  Oncogenes and human cancer--a surgeon's perspective.

Authors:  N I Markham
Journal:  Ann R Coll Surg Engl       Date:  1985-09       Impact factor: 1.891

5.  Hypercalcaemia and metastatic bone disease: is there a causal link?

Authors:  S Ralston; I Fogelman; M D Gardner; I T Boyle
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

6.  Expression of ras oncogene p21 in prostate cancer.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; G Finkel; J Lundy; P Hand; A Thor; J Schlom
Journal:  N Engl J Med       Date:  1986-01-16       Impact factor: 91.245

7.  Gastric carcinoma: is radical gastrectomy worth while?

Authors:  W P Longmire
Journal:  Ann R Coll Surg Engl       Date:  1980-01       Impact factor: 1.891

8.  Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

Authors:  I Elomaa; C Blomqvist; P Gröhn; L Porkka; A L Kairento; K Selander; C Lamberg-Allardt; T Holmström
Journal:  Lancet       Date:  1983-01-22       Impact factor: 79.321

9.  Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.

Authors:  S Adami; G Salvagno; G Guarrera; G Bianchi; R Dorizzi; S Rosini; G Mobilio; V Lo Cascio
Journal:  J Urol       Date:  1985-12       Impact factor: 7.450

10.  Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.

Authors:  R G Josse; T M Murray; G R Mundy; D Jez; J N Heersche
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.